InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Discover the detailed record of transactions filed by Sayad Pierre Sargis. Director active across 1 company, notably Fennec Pharmaceuticals INC.. Aggregated, 8 disclosures have been published. Split: 0 buy · 1 sell. Total volume traded: €126k. Activity tracked since 31 March 2026. The latest transaction was disclosed on 31 August 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 条申报中的 8 条
Sayad Pierre Sargis is an insider linked to Fennec Pharmaceuticals INC. on XNAS, where the listed role is Chief Medical Officer. The block shows 6 filings in total, and across the 6 sampled recent filings the date range runs from 2026-04-02 to 2026-08-03, with a modal transaction nature of option exercise and buy and sell amounts of EUR 0.